Prognostic Role of Inflammatory and Nutritional Biomarkers in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors Alone or in Combination with Chemotherapy as First-Line
Inflammatory and nutritional biomarkers such as the ALI, LIPI, PNI, and SIS represent useful tools to prognosticate survival in metastatic lung cancer patients treated with ICI alone or in combination with chemotherapy as first-line.
Authors
- Orazio Caffo
- Mariachiara Dipasquale
- Antonello Veccia (ORCID: https://orcid.org/0000-0002-8804-7094)
- Stefania Kinspergher
Institutions
- Ospedale Santa Chiara (IT)
Publication Details
- Journal
- Cancers
- Published
- 2024-11-19
- DOI
- https://doi.org/10.3390/cancers16223871
- Citations
- 3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.85